Miriam Yammine

Associate Director, Business Development, Pre-Clinical and Clinical Services @ Azenta Life Sciences

Country

City

France

Industry

Biotechnology

Skill

Molecular Biology, Cell Biology, Cell Culture, Biochemistry, Genetics, Lifesciences, qPCR, Bioinformatics, Animal Models, Flow Cytometry, Confocal Microscopy, In Vivo, Protein Expression, Fluorescence Microscopy, In Vitro, ELISA, Chromatin Immunoprecipitation, RNAseq, RNAi, Bio-informatique

Experience

Associate Director, Business Development, Pre-Clinical and Clinical Services

Azenta Life Sciences

2025-8 - Present · 1 yr 2 mos

EMEA

Senior Manager, Multiomics

Azenta Life Sciences

2024-3 - Present · 2 yrs 7 mos

Manager, Next Generation Sequencing

Azenta Life Sciences

2021-3 - 2024-3 · 3 yrs 1 mo

Associate Manager, Next Generation Sequencing

Azenta Life Sciences

2020-1 - 2021-3 · 1 yr 3 mos

Sr. Technical Application Scientist, Next Generation Sequencing

Azenta Life Sciences

2018-6 - 2020-1 · 1 yr 8 mos

Senior Scientist, Next Generation Sequencing

Azenta Life Sciences

2016-2 - 2018-6 · 2 yrs 5 mos

Europe

Project Manager, Next Generation Sequencing

Beckman Coulter Diagnostics

2015-2 - 2016-2 · 1 yr 1 mo

Danvers-USA, Takeley-UK

- Manage and Troubleshoot US and EU based NGS projects - Manage EU Sanger and NGS VIP accounts - Provide NGS Technical Support to Sales and Customers - Coordinate with Operations to deliver High Quality data - Implement new NGS services - Write and validate SOPs

Postdoctoral Research Fellow

Ecole normale supérieure

2013-10 - 2014-12 · 1 yr 3 mos

Région de Paris, France

I joined the 'Functional Imaging of Transcription' Team in order to decipher the molecular mechanisms sustaining cell fate. My focus was to understand how human skin fibroblasts accomplish their destiny to become myofibroblasts and allow wound healing.

Researcher Fellow and Project Manager

INSERM

2012-6 - 2013-8 · 1 yr 3 mos

Région de Marseille, France

I joined the The 'Transcriptomic and Genomic Marseille-Luminy (TGML)' to develop genome-wide investigating tools and technologies in order to identify the genetic and epigenetic variations that perturb the molecular networks in human diseases. I was also in charge of equipping the platform with the latest technologies for DNA sequencing. I have managed many projects based on next-generation sequencing concepts.